Menstrual Migraine: Why Ordinary Painkillers Often Fall Short

A menstrual migraine is not defined by how bad it feels. It is defined by when it arrives and what triggers it. The International Headache Society classifies it as a migraine occurring within the window of two days before menstruation to three days after it begins, in at least two out of three cycles. The trigger is not stress, not a skipped meal, not a change in sleep. It is a fall in oestrogen.

In the days before menstruation, oestrogen levels drop sharply. This drop reduces the brain's threshold for pain signalling. Oestrogen interacts with serotonin receptors and modulates how trigeminal nerve pathways, the network responsible for head and face pain, respond to stimulation. When oestrogen falls quickly, those pathways become easier to activate. The result is a migraine that tends to be longer, more severe, and more resistant to treatment than migraines occurring at other points in the cycle.

Standard over-the-counter analgesics work by suppressing inflammation or by blocking pain signals in general. Ibuprofen inhibits prostaglandins. Paracetamol acts on central pain modulation pathways. Both are genuinely effective for tension headaches and for mild-to-moderate pain where inflammation or general sensitisation is the driver.

A menstrual migraine is a different mechanism. The trigeminal nerve releases a peptide called CGRP, calcitonin gene-related peptide, which dilates blood vessels and sustains the pain cascade. Prostaglandin inhibition does not interrupt this cascade once it is running. Paracetamol does not either. The oestrogen drop that started the process is already done by the time the headache arrives. Taking ibuprofen at that point is targeting the wrong signal.

There is a second problem: timing. Most people take a painkiller when the pain is already established. By that point, the trigeminal pathway is sensitised, meaning the threshold for pain is lower and stimuli that would normally be neutral, light, sound, movement, are amplifying the headache. Analgesics taken after central sensitisation has set in are working against a process that is already self-sustaining.

Triptans, a class of prescription medicines that includes sumatriptan and rizatriptan, work by binding to serotonin receptors in the trigeminal pathway and causing vasoconstriction that interrupts the CGRP-driven cascade. They do not prevent the migraine, but taken early in the attack they can abort it before central sensitisation locks in. The Indian Association of Neurologists recognises triptans as first-line acute treatment for moderate-to-severe migraine, including menstrual migraine.

For women whose menstrual migraines are predictable, arriving in the same window each cycle, short-course preventive strategies exist. Frovatriptan taken in the days around the expected onset is one approach studied for this specific use. Non-steroidal anti-inflammatory drugs taken on a scheduled basis before the migraine begins, rather than in response to it, can reduce prostaglandin-driven sensitisation before it starts. These are not over-the-counter decisions. The doses, timing, and contraindications depend on individual cardiovascular and medication history.

A newer class of medicines, CGRP antagonists, targets the peptide directly rather than working through serotonin. These are available in India in limited settings and are primarily used for chronic or treatment-resistant migraine. A neurologist or gynaecologist with experience in headache medicine is the right person to assess whether any of these approaches fits a particular case.

Menstrual migraine is frequently misidentified for years because it looks like a bad period headache. The distinction matters because the treatment pathway is different. Keeping a record across three cycles, noting headache onset, severity, and where it falls relative to the start of menstruation, gives a doctor something concrete to work with. The pattern is what makes the diagnosis possible.

If the migraines are arriving consistently in the perimenstrual window, are lasting longer than 24 hours, or are not responding to the analgesics that work at other times of the month, that history is worth bringing to a gynaecologist or neurologist. It is not a question of pain tolerance. It is a question of whether the treatment matches the mechanism.